HYDROXYZINE HYDROCHLORIDE
NDC 10135-810, hydroxyzine hydrochloride, tablet, film coated, from Marlex Pharmaceuticals, Inc..
- Product NDC
- 10135-810
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207121
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROXYZINE DIHYDROCHLORIDE10 mg/1
Pharmacologic classes
Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-810-01 | 10135081001 | 100 TABLET, FILM COATED in 1 BOTTLE (10135-810-01) |
| 10135-810-10 | 10135081010 | 1000 TABLET, FILM COATED in 1 BOTTLE (10135-810-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/31a907e6-7fae-0682-e063-6294a90a24a5
Use it
Look up 10135-810 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-810. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.